subject: GlaxoSmithKline Expecting to Pay Billions to Settle Paxil Lawsuit Birth Defect Cases [print this page] GlaxoSmithKline Expecting to Pay Billions to Settle Paxil Lawsuit Birth Defect Cases
GlaxoSmithKline Expecting to Pay Billions to Settle Paxil Lawsuit Birth Defect Cases It's not breaking news that the antidepressant, Paxil, marketed by the pharmaceutical giant GlaxoSmithKline, is linked to causing Birth Defects when taken during the first trimester of pregnancy. Since the October 2009 trial, that paid $2.5 million dollars to the family of a three-year-old boy who was born with heart defects, that ruled GSK officials "negligently failed to warn" about Paxil's birth defect risk, the door has been opened to hundreds of families that have suffered similar stories to file their cases against GSK. Expected settlements average more than $1.25 million for each family that brings a Paxil lawsuit against the manufacturer alleging birth defects. Common Paxil related birth defects include:
Heart Malformations
Abdominal Birth Defects
Craniosynostosis
Club Foot & Cleft-lip
See the Full List of Injuries and Conditions
Paxil makers expect to pay more than $2.4 billion for recent drug allegations and product liability lawsuit brought by consumers that have suffered at the hands of the neglectful pharmaceutical company. If you were an expecting mother, that used Paxil between 1992 and 2007, and had a child that suffered birth defects, your family could be entitled to millions of dollars. Contact an experienced law firm that has a successful track record with and specializes in representing individuals injured by America's largest corporations. Visit our website to learn more about past Paxil lawsuits and the process that goes into filing a Paxil lawsuit settlement claims and our law firm.
GlaxoSmithKline also faces additonal filings regarding Product Liablility lawsuits coming from another drug they manufacture called Avandia. Avanida is a drug used to treat type 2 Diabetes that causes an increased risk in heart attack, heart failure, and cardiac death that they failed to alert the public to. The question is whether or not GSK will bounce back from all of the lawsuits and negative press they are getting from the media right now.
In terms of money, GSK was making more than $6 billion a year between Paxil and Avandia prescriptions. This doesn't include the dozens of other drugs the company markets. So I'd say financially, even if they pay BILLIONS of dollars in Settlements, the company should be able to survive, and hopefully open a new chapter in it's businesses life.
welcome to Insurances.net (https://www.insurances.net)
